Literature DB >> 16247981

Chemical synthesis of the novel Ca2+ messenger NAADP.

James Dowden1, Richard S Brown, Christelle Moreau, Antony Galione, Barry V L Potter.   

Abstract

The first total chemical synthesis of nicotinamide adenine dinucleotide phosphate (beta-NADP, 2) as a single isomer was achieved. This was subsequently converted into the important second messenger nicotinic acid adenine dinucleotide phosphate (p-NAADP) 1 and the identity of this material confirmed by biological evaluation. This flexible synthetic route offers new opportunities for the generation of NAADP 1 analogues that cannot be generated directly from NADP 2 or mainly enzymatic methods.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247981     DOI: 10.1081/ncn-200061786

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  4 in total

1.  Targeting Mycobacterium tuberculosis Biotin Protein Ligase (MtBPL) with Nucleoside-Based Bisubstrate Adenylation Inhibitors.

Authors:  Matthew R Bockman; Alvin S Kalinda; Riccardo Petrelli; Teresa De la Mora-Rey; Divya Tiwari; Feng Liu; Surrendra Dawadi; Madhumitha Nandakumar; Kyu Y Rhee; Dirk Schnappinger; Barry C Finzel; Courtney C Aldrich
Journal:  J Med Chem       Date:  2015-09-03       Impact factor: 7.446

2.  Nicotinic Acid Adenine Dinucleotide Phosphate Analogues Substituted on the Nicotinic Acid and Adenine Ribosides. Effects on ReceptorMediated Ca²⁺ Release.

Authors:  Christopher J Trabbic; Fan Zhang; Timothy F Walseth; James T Slama
Journal:  J Med Chem       Date:  2015-04-13       Impact factor: 7.446

3.  Chemoenzymatic Preparation of 4'-Thioribose NAD.

Authors:  Xiao-Nan Zhang; Zhefu Dai; Qinqin Cheng; Yong Zhang
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2019-04-05

4.  Small Molecule Antagonists of NAADP-Induced Ca2+ Release in T-Lymphocytes Suggest Potential Therapeutic Agents for Autoimmune Disease.

Authors:  Bo Zhang; Joanna M Watt; Chiara Cordiglieri; Werner Dammermann; Mary F Mahon; Alexander Flügel; Andreas H Guse; Barry V L Potter
Journal:  Sci Rep       Date:  2018-11-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.